Allegra and Urso 250 drug interactions - from FDA reports


Drug interactions are reported among people who take Allegra and Urso 250 together. This study is created by eHealthMe based on reports of 108 people who take Allegra and Urso 250 from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.


Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.



On Jan, 21, 2019

108 people who take Allegra, Urso 250 are studied.


Number of reports submitted per year:

Allegra and Urso 250 drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Duodenal ulcer
  2. Interstitial lung disease
  3. Rash
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Abdominal pain upper
  6. Cellulitis (infection under the skin)
  7. Decreased appetite
  8. Epistaxis (bleed from the nose)
  9. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
  10. Nausea (feeling of having an urge to vomit)
1 - 6 months:
  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Blood alkaline phosphatase increased
  3. Drug ineffective
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Osteoporosis (bones weak and more likely to break)
  6. Pruritus (severe itching of the skin)
  7. Spinal compression fracture (fracture due to spinal compression on bone)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Anaemia (lack of blood)
  10. Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
1 - 2 years:
  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Death
  3. Platelet count decreased
  4. Renal failure (kidney dysfunction)
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  6. Anxiety
  7. Cervicobrachial syndrome (pain in neck and arm with changing location)
  8. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  9. Pruritus (severe itching of the skin)
  10. Pyrexia (fever)
2 - 5 years:
  1. Hepatic failure (liver failure)
  2. Ammonia increased
  3. Pyrexia (fever)
  4. Vomiting
  5. Depressed level of consciousness
  6. Hypophagia (reduced food intake)
  7. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  8. Renal failure (kidney dysfunction)
5 - 10 years:

n/a

10+ years:
  1. C-reactive protein increased
  2. Decreased appetite
  3. Dementia (madness)
  4. Dyspnoea (difficult or laboured respiration)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Pruritus (severe itching of the skin)
  7. Chest discomfort
  8. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  9. Epistaxis (bleed from the nose)
  10. Nausea (feeling of having an urge to vomit)
not specified:
  1. Decreased appetite
  2. Pyrexia (fever)
  3. Headache (pain in head)
  4. Inflammation
  5. Cardiomyopathy (weakening of the heart muscle)
  6. Chills (felling of cold)
  7. Cholangitis (infection of the bile duct)
  8. Gastrointestinal hypomotility (less activity of the intestinal tract)
  9. Malignant neoplasm progression (cancer tumour came back)
  10. Oropharyngeal pain

Most common drug interactions by gender *:

female:
  1. Chills (felling of cold)
  2. Cholangitis (infection of the bile duct)
  3. Gastrointestinal hypomotility (less activity of the intestinal tract)
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Oropharyngeal pain
  6. Diarrhoea
  7. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Abdominal pain
male:
  1. Decreased appetite
  2. Anaemia (lack of blood)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Vomiting
  5. Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
  6. Dysphonia (speech disorder attributable to a disorder of phonation)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Nausea (feeling of having an urge to vomit)
  9. Pruritus (severe itching of the skin)
  10. Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:
  1. Alanine aminotransferase increased
  2. Anaemia (lack of blood)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Hyperbilirubinaemia (excess of bilirubin in the blood)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Muscular weakness (muscle weakness)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Platelet count decreased
  9. Stomatitis (inflammation of mucous membrane of mouth)
  10. White blood cell count decreased
20-29:

n/a

30-39:
  1. Alanine aminotransferase increased
  2. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  3. Aspartate aminotransferase increased
  4. Blood bilirubin increased
  5. Blood creatinine increased
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  8. Diarrhoea
  9. Disease progression
  10. Febrile neutropenia (fever with reduced white blood cells)
50-59:
  1. Pyrexia (fever)
  2. Cardiomyopathy (weakening of the heart muscle)
  3. Chills (felling of cold)
  4. Cholangitis (infection of the bile duct)
  5. Gastrointestinal hypomotility (less activity of the intestinal tract)
  6. Headache (pain in head)
  7. Inflammation
  8. Malignant neoplasm progression (cancer tumour came back)
  9. Oropharyngeal pain
  10. Sepsis (a severe blood infection that can lead to organ failure and death)
60+:
  1. Decreased appetite
  2. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  3. C-reactive protein increased
  4. Interstitial lung disease
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Pruritus (severe itching of the skin)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Vomiting
  9. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  10. Anaemia (lack of blood)

* Approximation only. Some reports may have incomplete information.

Do you take Allegra and Urso 250?


You are not alone:




Related studies

Allegra

Allegra has active ingredients of fexofenadine hydrochloride. It is often used in allergies. (latest outcomes from Allegra 53,163 users)

Urso 250

Urso 250 has active ingredients of ursodiol. (latest outcomes from Urso 250 5,033 users)


Browse by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Allegra and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Urso 250 and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Allegra and Urso 250
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Allegra and Urso 250

FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!